HYPD
HYPD
NASDAQ · Pharmaceuticals

Hyperion Defi Inc

$4.18
+0.15 (+3.59%)
As of May 9, 2:16 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +286.1% upside
Low Target $9.68
Average Target $16.14
High Target $20.98
Current Price $4.18
Current
$4.18
Target
$16.14
$9.68 $16.14 avg $20.98
Scenario Analysis
Bear Case
$9.68
131.6%
Low target
Base Case
$16.14
+286.1%
Avg target
Bull Case
$20.98
+401.9%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$17.18
-75.7% from high
52-Week Low
$1.03
+305.8% from low
Target vs 52W High
$16.14
-6.1% vs high
Next Earnings Report
May 14, 2026 · Before Market Open
3d
until earnings
EPS Est: $0.74
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%